chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle spasms, Nightmare, Troponin normal
Clinical narrative: I received the Janssen COVAX on Monday morning, 5 Apr 2021.  A week later, on Monday evening, 12 Apr 2021, I experienced extremely painful leg cramps and broke out in a sweat. I felt extremely nauseous, and weak, this was followed by a sever pain in my head that was so extreme that I passed out. After coming to, the pain in my head finally began to subside, along with the leg cramps. My husband indicated that I was unconscious for just under a minute.  For the next two days, I had bouts of nausea, headaches, sweats, and was extremely tired.  On Wednesday, 14 Apr, after learning of the issues related to the Janssen vaccine, and the symptoms described being what I experienced, I contacted the advice (cont'd)..Additional information for Item 18: Line and was told to go to Emergency Room at the hospital, which I did.  I do not feel that they addressed my concerns or the symptoms that I was experiencing, and at no time did they try to determine if it was due to the vaccine.  The discharge papers did not even address the "event" and the "symptoms" that I described.  They did not take any information down related to the vaccine, lot number, etc., that I had received.  They seemed to go through a set routine:  blood pressure, blood work, temperature, EKG, and CAT scan.    21. (continued)...Visited Emergency Room, however, was requested by ER to go to Primary Care as follow-up, however, as a  Employee we cannot be seen by Primary Care on THIS site.  Instead , we have to go on the local clinic to receive care.  The issue is that this was a vaccine that I was scheduled by my leadership to receive, with no choice in choosing which vaccine I could receive, and without follow-up care for adverse reactions. The hospital did not indicate to me that I should report this incident, however, I am concerned as a result of the "event" that I experienced, that it should be reported.  Furthermore,we should have a choice as to which vaccine we want to receive, just as everyone does.  Your form does not allow for input addresses  Also, your form does not allow for a phone number.  I am out of the country.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Computerised tomogram, Electrocardiogram, Fatigue, Headache
Clinical narrative: I received the Janssen COVAX on Monday morning, 5 Apr 2021.  A week later, on Monday evening, 12 Apr 2021, I experienced extremely painful leg cramps and broke out in a sweat. I felt extremely nauseous, and weak, this was followed by a sever pain in my head that was so extreme that I passed out. After coming to, the pain in my head finally began to subside, along with the leg cramps. My husband indicated that I was unconscious for just under a minute.  For the next two days, I had bouts of nausea, headaches, sweats, and was extremely tired.  On Wednesday, 14 Apr, after learning of the issues related to the Janssen vaccine, and the symptoms described being what I experienced, I contacted the advice (cont'd)..Additional information for Item 18: Line and was told to go to Emergency Room at the hospital, which I did.  I do not feel that they addressed my concerns or the symptoms that I was experiencing, and at no time did they try to determine if it was due to the vaccine.  The discharge papers did not even address the "event" and the "symptoms" that I described.  They did not take any information down related to the vaccine, lot number, etc., that I had received.  They seemed to go through a set routine:  blood pressure, blood work, temperature, EKG, and CAT scan.    21. (continued)...Visited Emergency Room, however, was requested by ER to go to Primary Care as follow-up, however, as a  Employee we cannot be seen by Primary Care on THIS site.  Instead , we have to go on the local clinic to receive care.  The issue is that this was a vaccine that I was scheduled by my leadership to receive, with no choice in choosing which vaccine I could receive, and without follow-up care for adverse reactions. The hospital did not indicate to me that I should report this incident, however, I am concerned as a result of the "event" that I experienced, that it should be reported.  Furthermore,we should have a choice as to which vaccine we want to receive, just as everyone does.  Your form does not allow for input addresses  Also, your form does not allow for a phone number.  I am out of the country.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Laboratory test, Loss of consciousness, Muscle spasms, Nausea
Clinical narrative: I received the Janssen COVAX on Monday morning, 5 Apr 2021.  A week later, on Monday evening, 12 Apr 2021, I experienced extremely painful leg cramps and broke out in a sweat. I felt extremely nauseous, and weak, this was followed by a sever pain in my head that was so extreme that I passed out. After coming to, the pain in my head finally began to subside, along with the leg cramps. My husband indicated that I was unconscious for just under a minute.  For the next two days, I had bouts of nausea, headaches, sweats, and was extremely tired.  On Wednesday, 14 Apr, after learning of the issues related to the Janssen vaccine, and the symptoms described being what I experienced, I contacted the advice (cont'd)..Additional information for Item 18: Line and was told to go to Emergency Room at the hospital, which I did.  I do not feel that they addressed my concerns or the symptoms that I was experiencing, and at no time did they try to determine if it was due to the vaccine.  The discharge papers did not even address the "event" and the "symptoms" that I described.  They did not take any information down related to the vaccine, lot number, etc., that I had received.  They seemed to go through a set routine:  blood pressure, blood work, temperature, EKG, and CAT scan.    21. (continued)...Visited Emergency Room, however, was requested by ER to go to Primary Care as follow-up, however, as a  Employee we cannot be seen by Primary Care on THIS site.  Instead , we have to go on the local clinic to receive care.  The issue is that this was a vaccine that I was scheduled by my leadership to receive, with no choice in choosing which vaccine I could receive, and without follow-up care for adverse reactions. The hospital did not indicate to me that I should report this incident, however, I am concerned as a result of the "event" that I experienced, that it should be reported.  Furthermore,we should have a choice as to which vaccine we want to receive, just as everyone does.  Your form does not allow for input addresses  Also, your form does not allow for a phone number.  I am out of the country.
Age: 78.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Angiogram, Cerebrovascular accident, Computerised tomogram, Magnetic resonance imaging, Memory impairment
Clinical narrative: Shortly after my dad got the Johnson and Johnson vaccine, he had a stroke due to a blood clot to the brain. He had the Covid virus back in December.  Other than that, he has been a perfectly healthy 78 year old.
Age: 78.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Thrombosis, Ultrasound scan, Visual impairment
Clinical narrative: Shortly after my dad got the Johnson and Johnson vaccine, he had a stroke due to a blood clot to the brain. He had the Covid virus back in December.  Other than that, he has been a perfectly healthy 78 year old.
Age: 78.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Cerebral thrombosis, Cerebrovascular accident, Visual impairment
Clinical narrative: Shortly after my dad got the Johnson and Johnson vaccine, he had a stroke due to a blood clot to the brain. He had the Covid virus back in December.  Other than that, he has been a perfectly healthy 78 year old.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Nausea, Pain in extremity, Peripheral swelling, Sciatica
Clinical narrative: Entire left leg extensive DVT
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ultrasound scan
Clinical narrative: Entire left leg extensive DVT
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Ultrasound Doppler
Clinical narrative: Entire left leg extensive DVT
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, Chest discomfort, Chest pain, Electrocardiogram normal, Influenza virus test negative
Clinical narrative: This is a 27 y.o. female with a PMH of hypothyroidism, obesity, and chronic migraines who presented to ED on 4/13/21 for evaluation of chest pain. In the ED, her troponin was elevated at 1.73. EKG showed NSR with nonspecific t-wave abnormality. CTA chest and CXR were negative for acute findings. She was given 325 mg aspirin and cardiology was consulted. Hospital was asked to admit for ongoing evaluation and management.    Her troponin was trended and peaked at 9.59, trended down to 8.18 on the day of discharge.  Echocardiogram showed normal LVEF at 62% and no wall motion abnormalities. Her CRP was elevated at 25.5. Cardiac MRI 4/14 showed evidence of epicardial delayed enhancement consistent with myocarditis, no evidence of myocardial infarction. She was diagnosed with myocarditis, possibly related to recent Pfizer COVID vaccination (vs other viral etiologies). ID was consulted and added on labs to rule out a mild case of MIS-A as well.  Labs pending at time of d/c (ferritin, d dimer, CRP/ESR, COVID total AB, and IL-6).  Depending on results, PCP may consider outpatient referral to rheumatology.    Discussed with her to only have mild to moderate physical activity for the next 12 weeks, avoid or limit alcohol, and limit caffeine intake. F/u with cardiology in 2-3 weeks, and PCP in 1 week.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging heart, Myocarditis, Respiratory syncytial virus test negative, Respiratory viral panel, SARS-CoV-2 test negative
Clinical narrative: This is a 27 y.o. female with a PMH of hypothyroidism, obesity, and chronic migraines who presented to ED on 4/13/21 for evaluation of chest pain. In the ED, her troponin was elevated at 1.73. EKG showed NSR with nonspecific t-wave abnormality. CTA chest and CXR were negative for acute findings. She was given 325 mg aspirin and cardiology was consulted. Hospital was asked to admit for ongoing evaluation and management.    Her troponin was trended and peaked at 9.59, trended down to 8.18 on the day of discharge.  Echocardiogram showed normal LVEF at 62% and no wall motion abnormalities. Her CRP was elevated at 25.5. Cardiac MRI 4/14 showed evidence of epicardial delayed enhancement consistent with myocarditis, no evidence of myocardial infarction. She was diagnosed with myocarditis, possibly related to recent Pfizer COVID vaccination (vs other viral etiologies). ID was consulted and added on labs to rule out a mild case of MIS-A as well.  Labs pending at time of d/c (ferritin, d dimer, CRP/ESR, COVID total AB, and IL-6).  Depending on results, PCP may consider outpatient referral to rheumatology.    Discussed with her to only have mild to moderate physical activity for the next 12 weeks, avoid or limit alcohol, and limit caffeine intake. F/u with cardiology in 2-3 weeks, and PCP in 1 week.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Troponin
Clinical narrative: This is a 27 y.o. female with a PMH of hypothyroidism, obesity, and chronic migraines who presented to ED on 4/13/21 for evaluation of chest pain. In the ED, her troponin was elevated at 1.73. EKG showed NSR with nonspecific t-wave abnormality. CTA chest and CXR were negative for acute findings. She was given 325 mg aspirin and cardiology was consulted. Hospital was asked to admit for ongoing evaluation and management.    Her troponin was trended and peaked at 9.59, trended down to 8.18 on the day of discharge.  Echocardiogram showed normal LVEF at 62% and no wall motion abnormalities. Her CRP was elevated at 25.5. Cardiac MRI 4/14 showed evidence of epicardial delayed enhancement consistent with myocarditis, no evidence of myocardial infarction. She was diagnosed with myocarditis, possibly related to recent Pfizer COVID vaccination (vs other viral etiologies). ID was consulted and added on labs to rule out a mild case of MIS-A as well.  Labs pending at time of d/c (ferritin, d dimer, CRP/ESR, COVID total AB, and IL-6).  Depending on results, PCP may consider outpatient referral to rheumatology.    Discussed with her to only have mild to moderate physical activity for the next 12 weeks, avoid or limit alcohol, and limit caffeine intake. F/u with cardiology in 2-3 weeks, and PCP in 1 week.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase normal, Angiogram pulmonary normal, Aspartate aminotransferase normal, Blood albumin decreased, Blood alkaline phosphatase normal
Clinical narrative: This is a 27 y.o. female with a PMH of hypothyroidism, obesity, and chronic migraines who presented to ED on 4/13/21 for evaluation of chest pain. In the ED, her troponin was elevated at 1.73. EKG showed NSR with nonspecific t-wave abnormality. CTA chest and CXR were negative for acute findings. She was given 325 mg aspirin and cardiology was consulted. Hospital was asked to admit for ongoing evaluation and management.    Her troponin was trended and peaked at 9.59, trended down to 8.18 on the day of discharge.  Echocardiogram showed normal LVEF at 62% and no wall motion abnormalities. Her CRP was elevated at 25.5. Cardiac MRI 4/14 showed evidence of epicardial delayed enhancement consistent with myocarditis, no evidence of myocardial infarction. She was diagnosed with myocarditis, possibly related to recent Pfizer COVID vaccination (vs other viral etiologies). ID was consulted and added on labs to rule out a mild case of MIS-A as well.  Labs pending at time of d/c (ferritin, d dimer, CRP/ESR, COVID total AB, and IL-6).  Depending on results, PCP may consider outpatient referral to rheumatology.    Discussed with her to only have mild to moderate physical activity for the next 12 weeks, avoid or limit alcohol, and limit caffeine intake. F/u with cardiology in 2-3 weeks, and PCP in 1 week.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood bilirubin normal, Blood calcium decreased, Blood chloride increased, Blood creatinine normal, Blood glucose normal
Clinical narrative: This is a 27 y.o. female with a PMH of hypothyroidism, obesity, and chronic migraines who presented to ED on 4/13/21 for evaluation of chest pain. In the ED, her troponin was elevated at 1.73. EKG showed NSR with nonspecific t-wave abnormality. CTA chest and CXR were negative for acute findings. She was given 325 mg aspirin and cardiology was consulted. Hospital was asked to admit for ongoing evaluation and management.    Her troponin was trended and peaked at 9.59, trended down to 8.18 on the day of discharge.  Echocardiogram showed normal LVEF at 62% and no wall motion abnormalities. Her CRP was elevated at 25.5. Cardiac MRI 4/14 showed evidence of epicardial delayed enhancement consistent with myocarditis, no evidence of myocardial infarction. She was diagnosed with myocarditis, possibly related to recent Pfizer COVID vaccination (vs other viral etiologies). ID was consulted and added on labs to rule out a mild case of MIS-A as well.  Labs pending at time of d/c (ferritin, d dimer, CRP/ESR, COVID total AB, and IL-6).  Depending on results, PCP may consider outpatient referral to rheumatology.    Discussed with her to only have mild to moderate physical activity for the next 12 weeks, avoid or limit alcohol, and limit caffeine intake. F/u with cardiology in 2-3 weeks, and PCP in 1 week.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood potassium normal, Blood sodium normal, Blood triglycerides increased, Blood urea normal, C-reactive protein increased
Clinical narrative: This is a 27 y.o. female with a PMH of hypothyroidism, obesity, and chronic migraines who presented to ED on 4/13/21 for evaluation of chest pain. In the ED, her troponin was elevated at 1.73. EKG showed NSR with nonspecific t-wave abnormality. CTA chest and CXR were negative for acute findings. She was given 325 mg aspirin and cardiology was consulted. Hospital was asked to admit for ongoing evaluation and management.    Her troponin was trended and peaked at 9.59, trended down to 8.18 on the day of discharge.  Echocardiogram showed normal LVEF at 62% and no wall motion abnormalities. Her CRP was elevated at 25.5. Cardiac MRI 4/14 showed evidence of epicardial delayed enhancement consistent with myocarditis, no evidence of myocardial infarction. She was diagnosed with myocarditis, possibly related to recent Pfizer COVID vaccination (vs other viral etiologies). ID was consulted and added on labs to rule out a mild case of MIS-A as well.  Labs pending at time of d/c (ferritin, d dimer, CRP/ESR, COVID total AB, and IL-6).  Depending on results, PCP may consider outpatient referral to rheumatology.    Discussed with her to only have mild to moderate physical activity for the next 12 weeks, avoid or limit alcohol, and limit caffeine intake. F/u with cardiology in 2-3 weeks, and PCP in 1 week.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Carbon dioxide normal, Chest X-ray normal, Chest pain, Creatinine renal clearance increased, Echocardiogram normal
Clinical narrative: This is a 27 y.o. female with a PMH of hypothyroidism, obesity, and chronic migraines who presented to ED on 4/13/21 for evaluation of chest pain. In the ED, her troponin was elevated at 1.73. EKG showed NSR with nonspecific t-wave abnormality. CTA chest and CXR were negative for acute findings. She was given 325 mg aspirin and cardiology was consulted. Hospital was asked to admit for ongoing evaluation and management.    Her troponin was trended and peaked at 9.59, trended down to 8.18 on the day of discharge.  Echocardiogram showed normal LVEF at 62% and no wall motion abnormalities. Her CRP was elevated at 25.5. Cardiac MRI 4/14 showed evidence of epicardial delayed enhancement consistent with myocarditis, no evidence of myocardial infarction. She was diagnosed with myocarditis, possibly related to recent Pfizer COVID vaccination (vs other viral etiologies). ID was consulted and added on labs to rule out a mild case of MIS-A as well.  Labs pending at time of d/c (ferritin, d dimer, CRP/ESR, COVID total AB, and IL-6).  Depending on results, PCP may consider outpatient referral to rheumatology.    Discussed with her to only have mild to moderate physical activity for the next 12 weeks, avoid or limit alcohol, and limit caffeine intake. F/u with cardiology in 2-3 weeks, and PCP in 1 week.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram T wave abnormal, Fibrin D dimer, Fibrin D dimer increased, Haematocrit normal, Haemoglobin normal
Clinical narrative: This is a 27 y.o. female with a PMH of hypothyroidism, obesity, and chronic migraines who presented to ED on 4/13/21 for evaluation of chest pain. In the ED, her troponin was elevated at 1.73. EKG showed NSR with nonspecific t-wave abnormality. CTA chest and CXR were negative for acute findings. She was given 325 mg aspirin and cardiology was consulted. Hospital was asked to admit for ongoing evaluation and management.    Her troponin was trended and peaked at 9.59, trended down to 8.18 on the day of discharge.  Echocardiogram showed normal LVEF at 62% and no wall motion abnormalities. Her CRP was elevated at 25.5. Cardiac MRI 4/14 showed evidence of epicardial delayed enhancement consistent with myocarditis, no evidence of myocardial infarction. She was diagnosed with myocarditis, possibly related to recent Pfizer COVID vaccination (vs other viral etiologies). ID was consulted and added on labs to rule out a mild case of MIS-A as well.  Labs pending at time of d/c (ferritin, d dimer, CRP/ESR, COVID total AB, and IL-6).  Depending on results, PCP may consider outpatient referral to rheumatology.    Discussed with her to only have mild to moderate physical activity for the next 12 weeks, avoid or limit alcohol, and limit caffeine intake. F/u with cardiology in 2-3 weeks, and PCP in 1 week.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: High density lipoprotein normal, Interleukin level, LDL/HDL ratio increased, Low density lipoprotein increased, Lymphocyte count normal
Clinical narrative: This is a 27 y.o. female with a PMH of hypothyroidism, obesity, and chronic migraines who presented to ED on 4/13/21 for evaluation of chest pain. In the ED, her troponin was elevated at 1.73. EKG showed NSR with nonspecific t-wave abnormality. CTA chest and CXR were negative for acute findings. She was given 325 mg aspirin and cardiology was consulted. Hospital was asked to admit for ongoing evaluation and management.    Her troponin was trended and peaked at 9.59, trended down to 8.18 on the day of discharge.  Echocardiogram showed normal LVEF at 62% and no wall motion abnormalities. Her CRP was elevated at 25.5. Cardiac MRI 4/14 showed evidence of epicardial delayed enhancement consistent with myocarditis, no evidence of myocardial infarction. She was diagnosed with myocarditis, possibly related to recent Pfizer COVID vaccination (vs other viral etiologies). ID was consulted and added on labs to rule out a mild case of MIS-A as well.  Labs pending at time of d/c (ferritin, d dimer, CRP/ESR, COVID total AB, and IL-6).  Depending on results, PCP may consider outpatient referral to rheumatology.    Discussed with her to only have mild to moderate physical activity for the next 12 weeks, avoid or limit alcohol, and limit caffeine intake. F/u with cardiology in 2-3 weeks, and PCP in 1 week.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging abnormal, Magnetic resonance imaging heart, Mean cell volume normal, Myocarditis, Non-high-density lipoprotein cholesterol increased
Clinical narrative: This is a 27 y.o. female with a PMH of hypothyroidism, obesity, and chronic migraines who presented to ED on 4/13/21 for evaluation of chest pain. In the ED, her troponin was elevated at 1.73. EKG showed NSR with nonspecific t-wave abnormality. CTA chest and CXR were negative for acute findings. She was given 325 mg aspirin and cardiology was consulted. Hospital was asked to admit for ongoing evaluation and management.    Her troponin was trended and peaked at 9.59, trended down to 8.18 on the day of discharge.  Echocardiogram showed normal LVEF at 62% and no wall motion abnormalities. Her CRP was elevated at 25.5. Cardiac MRI 4/14 showed evidence of epicardial delayed enhancement consistent with myocarditis, no evidence of myocardial infarction. She was diagnosed with myocarditis, possibly related to recent Pfizer COVID vaccination (vs other viral etiologies). ID was consulted and added on labs to rule out a mild case of MIS-A as well.  Labs pending at time of d/c (ferritin, d dimer, CRP/ESR, COVID total AB, and IL-6).  Depending on results, PCP may consider outpatient referral to rheumatology.    Discussed with her to only have mild to moderate physical activity for the next 12 weeks, avoid or limit alcohol, and limit caffeine intake. F/u with cardiology in 2-3 weeks, and PCP in 1 week.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Platelet count normal, Protein total normal, Red blood cell count normal, Red blood cell sedimentation rate, SARS-CoV-2 antibody test
Clinical narrative: This is a 27 y.o. female with a PMH of hypothyroidism, obesity, and chronic migraines who presented to ED on 4/13/21 for evaluation of chest pain. In the ED, her troponin was elevated at 1.73. EKG showed NSR with nonspecific t-wave abnormality. CTA chest and CXR were negative for acute findings. She was given 325 mg aspirin and cardiology was consulted. Hospital was asked to admit for ongoing evaluation and management.    Her troponin was trended and peaked at 9.59, trended down to 8.18 on the day of discharge.  Echocardiogram showed normal LVEF at 62% and no wall motion abnormalities. Her CRP was elevated at 25.5. Cardiac MRI 4/14 showed evidence of epicardial delayed enhancement consistent with myocarditis, no evidence of myocardial infarction. She was diagnosed with myocarditis, possibly related to recent Pfizer COVID vaccination (vs other viral etiologies). ID was consulted and added on labs to rule out a mild case of MIS-A as well.  Labs pending at time of d/c (ferritin, d dimer, CRP/ESR, COVID total AB, and IL-6).  Depending on results, PCP may consider outpatient referral to rheumatology.    Discussed with her to only have mild to moderate physical activity for the next 12 weeks, avoid or limit alcohol, and limit caffeine intake. F/u with cardiology in 2-3 weeks, and PCP in 1 week.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Serum ferritin, Total cholesterol/HDL ratio normal, Troponin I increased, Troponin increased, Very low density lipoprotein increased
Clinical narrative: This is a 27 y.o. female with a PMH of hypothyroidism, obesity, and chronic migraines who presented to ED on 4/13/21 for evaluation of chest pain. In the ED, her troponin was elevated at 1.73. EKG showed NSR with nonspecific t-wave abnormality. CTA chest and CXR were negative for acute findings. She was given 325 mg aspirin and cardiology was consulted. Hospital was asked to admit for ongoing evaluation and management.    Her troponin was trended and peaked at 9.59, trended down to 8.18 on the day of discharge.  Echocardiogram showed normal LVEF at 62% and no wall motion abnormalities. Her CRP was elevated at 25.5. Cardiac MRI 4/14 showed evidence of epicardial delayed enhancement consistent with myocarditis, no evidence of myocardial infarction. She was diagnosed with myocarditis, possibly related to recent Pfizer COVID vaccination (vs other viral etiologies). ID was consulted and added on labs to rule out a mild case of MIS-A as well.  Labs pending at time of d/c (ferritin, d dimer, CRP/ESR, COVID total AB, and IL-6).  Depending on results, PCP may consider outpatient referral to rheumatology.    Discussed with her to only have mild to moderate physical activity for the next 12 weeks, avoid or limit alcohol, and limit caffeine intake. F/u with cardiology in 2-3 weeks, and PCP in 1 week.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: White blood cell count normal
Clinical narrative: This is a 27 y.o. female with a PMH of hypothyroidism, obesity, and chronic migraines who presented to ED on 4/13/21 for evaluation of chest pain. In the ED, her troponin was elevated at 1.73. EKG showed NSR with nonspecific t-wave abnormality. CTA chest and CXR were negative for acute findings. She was given 325 mg aspirin and cardiology was consulted. Hospital was asked to admit for ongoing evaluation and management.    Her troponin was trended and peaked at 9.59, trended down to 8.18 on the day of discharge.  Echocardiogram showed normal LVEF at 62% and no wall motion abnormalities. Her CRP was elevated at 25.5. Cardiac MRI 4/14 showed evidence of epicardial delayed enhancement consistent with myocarditis, no evidence of myocardial infarction. She was diagnosed with myocarditis, possibly related to recent Pfizer COVID vaccination (vs other viral etiologies). ID was consulted and added on labs to rule out a mild case of MIS-A as well.  Labs pending at time of d/c (ferritin, d dimer, CRP/ESR, COVID total AB, and IL-6).  Depending on results, PCP may consider outpatient referral to rheumatology.    Discussed with her to only have mild to moderate physical activity for the next 12 weeks, avoid or limit alcohol, and limit caffeine intake. F/u with cardiology in 2-3 weeks, and PCP in 1 week.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Dyspnoea, Lethargy, Unresponsive to stimuli
Clinical narrative: Within 20 mins of receiving the vaccine, had difficulty breathing and dizziness.  EMT at site was called who administered oxygen and monitored vitals.  911 ambulance was called and they administered Benadryl due to continued difficulty in breathing and rash observed developing around neck area, heart rate was @ 180.  Patient was rushed to ER and then admitted to hospital for 1 day, as difficulty in breathing, weakness and high pulse rate continued.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Wheezing
Clinical narrative: Within 20 mins of receiving the vaccine, had difficulty breathing and dizziness.  EMT at site was called who administered oxygen and monitored vitals.  911 ambulance was called and they administered Benadryl due to continued difficulty in breathing and rash observed developing around neck area, heart rate was @ 180.  Patient was rushed to ER and then admitted to hospital for 1 day, as difficulty in breathing, weakness and high pulse rate continued.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Dyspnoea, Heart rate increased, Rash
Clinical narrative: Within 20 mins of receiving the vaccine, had difficulty breathing and dizziness.  EMT at site was called who administered oxygen and monitored vitals.  911 ambulance was called and they administered Benadryl due to continued difficulty in breathing and rash observed developing around neck area, heart rate was @ 180.  Patient was rushed to ER and then admitted to hospital for 1 day, as difficulty in breathing, weakness and high pulse rate continued.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death, Dyspnoea, Loss of consciousness, Unresponsive to stimuli
Clinical narrative: He got his vaccine, son talked to him 5 minutes a night but does not remember him saying that he had any side effects other than being really tired.  To his son he sounded alright.  His best friend that he complained about being short of breath and that his hands were shaking when he got off of work.  His Fiance handed him some food and noticed that his hands were shaking.  He then did some laundry and took a shower and seemed fine to her (according to his son).  the fiance said that she heard him collapse and looked like he was sleeping, she called 9-1-1 and they pronounced dead on 4/14/21.  They said that he had a heart attack, but did not have any history of heart issues.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood calcium normal, Blood chloride normal, Blood creatinine increased, Blood glucose increased, Blood potassium normal
Clinical narrative: He got his vaccine, son talked to him 5 minutes a night but does not remember him saying that he had any side effects other than being really tired.  To his son he sounded alright.  His best friend that he complained about being short of breath and that his hands were shaking when he got off of work.  His Fiance handed him some food and noticed that his hands were shaking.  He then did some laundry and took a shower and seemed fine to her (according to his son).  the fiance said that she heard him collapse and looked like he was sleeping, she called 9-1-1 and they pronounced dead on 4/14/21.  They said that he had a heart attack, but did not have any history of heart issues.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood sodium normal, Blood urea normal, Carbon dioxide decreased, Death, Dyspnoea
Clinical narrative: He got his vaccine, son talked to him 5 minutes a night but does not remember him saying that he had any side effects other than being really tired.  To his son he sounded alright.  His best friend that he complained about being short of breath and that his hands were shaking when he got off of work.  His Fiance handed him some food and noticed that his hands were shaking.  He then did some laundry and took a shower and seemed fine to her (according to his son).  the fiance said that she heard him collapse and looked like he was sleeping, she called 9-1-1 and they pronounced dead on 4/14/21.  They said that he had a heart attack, but did not have any history of heart issues.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Haematocrit decreased, Haemoglobin decreased
Clinical narrative: He got his vaccine, son talked to him 5 minutes a night but does not remember him saying that he had any side effects other than being really tired.  To his son he sounded alright.  His best friend that he complained about being short of breath and that his hands were shaking when he got off of work.  His Fiance handed him some food and noticed that his hands were shaking.  He then did some laundry and took a shower and seemed fine to her (according to his son).  the fiance said that she heard him collapse and looked like he was sleeping, she called 9-1-1 and they pronounced dead on 4/14/21.  They said that he had a heart attack, but did not have any history of heart issues.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death, Dyspnoea, Fatigue, Myocardial infarction, Syncope
Clinical narrative: He got his vaccine, son talked to him 5 minutes a night but does not remember him saying that he had any side effects other than being really tired.  To his son he sounded alright.  His best friend that he complained about being short of breath and that his hands were shaking when he got off of work.  His Fiance handed him some food and noticed that his hands were shaking.  He then did some laundry and took a shower and seemed fine to her (according to his son).  the fiance said that she heard him collapse and looked like he was sleeping, she called 9-1-1 and they pronounced dead on 4/14/21.  They said that he had a heart attack, but did not have any history of heart issues.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tremor
Clinical narrative: He got his vaccine, son talked to him 5 minutes a night but does not remember him saying that he had any side effects other than being really tired.  To his son he sounded alright.  His best friend that he complained about being short of breath and that his hands were shaking when he got off of work.  His Fiance handed him some food and noticed that his hands were shaking.  He then did some laundry and took a shower and seemed fine to her (according to his son).  the fiance said that she heard him collapse and looked like he was sleeping, she called 9-1-1 and they pronounced dead on 4/14/21.  They said that he had a heart attack, but did not have any history of heart issues.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electroencephalogram, Gait disturbance, Seizure
Clinical narrative: I experienced a severe brain seizure! I am a 4 year Brain Cancer survivor and I have never had a seizure
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Seizure
Clinical narrative: I experienced a severe brain seizure! I am a 4 year Brain Cancer survivor and I have never had a seizure
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Body temperature, Fatigue, Feeling hot, Headache
Clinical narrative: ARM WAS RED; FELT LIKE SOMEONE PUNCHED  OVERNIGHT AND ARM WAS GOING TO FALL OFF; HIGH FEVER; ARM REALLY SORE; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, migraine, ulcer, penicillin allergy, and sulfa allergy. The patient was previously treated with lansoprazole for ulcer. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced nausea. On 10-MAR-2021, the subject experienced high fever. On 10-MAR-2021, the subject experienced arm really sore. On 11-MAR-2021, the subject experienced arm was red. On 11-MAR-2021, the subject experienced felt like someone punched overnight and arm was going to fall off. Laboratory data included: Fever (NR: not provided) 101.8 F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from high fever, nausea, arm really sore, arm was red, and felt like someone punched overnight and arm was going to fall off. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nasal congestion, Nausea, Pyrexia
Clinical narrative: ARM WAS RED; FELT LIKE SOMEONE PUNCHED  OVERNIGHT AND ARM WAS GOING TO FALL OFF; HIGH FEVER; ARM REALLY SORE; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, migraine, ulcer, penicillin allergy, and sulfa allergy. The patient was previously treated with lansoprazole for ulcer. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced nausea. On 10-MAR-2021, the subject experienced high fever. On 10-MAR-2021, the subject experienced arm really sore. On 11-MAR-2021, the subject experienced arm was red. On 11-MAR-2021, the subject experienced felt like someone punched overnight and arm was going to fall off. Laboratory data included: Fever (NR: not provided) 101.8 F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from high fever, nausea, arm really sore, arm was red, and felt like someone punched overnight and arm was going to fall off. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Hypoaesthesia, Nausea, Pain in extremity, Pyrexia
Clinical narrative: ARM WAS RED; FELT LIKE SOMEONE PUNCHED  OVERNIGHT AND ARM WAS GOING TO FALL OFF; HIGH FEVER; ARM REALLY SORE; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, migraine, ulcer, penicillin allergy, and sulfa allergy. The patient was previously treated with lansoprazole for ulcer. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced nausea. On 10-MAR-2021, the subject experienced high fever. On 10-MAR-2021, the subject experienced arm really sore. On 11-MAR-2021, the subject experienced arm was red. On 11-MAR-2021, the subject experienced felt like someone punched overnight and arm was going to fall off. Laboratory data included: Fever (NR: not provided) 101.8 F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from high fever, nausea, arm really sore, arm was red, and felt like someone punched overnight and arm was going to fall off. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood pressure measurement, Dizziness, Dyspnoea, Heart rate, Nausea
Clinical narrative: FAINTED; SEIZURE; STOPPED BREATHING; LIGHT HEADED; CYANOSIS; This spontaneous report received from a health care professional (public health nurse) concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 043A21A, and expiry: 31-DEC-2069) dose was not reported, 1 total, administered on left arm on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, about 5 minutes after vaccination, the patient experienced lightheadedness, then fainted, had a seizure, stopped breathing (for 10 seconds), and developed cyanosis (turned blue). The nurse did cardiopulmonary resuscitation (CPR) and the Emergency Medical Services (EMS) was called. By the time the EMS arrived, the patient felt better. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stopped breathing on 07-APR-2021, and was recovering from light headed, fainted, seizure, and cyanosis. This report was serious (Other Medically Important Condition, and Life Threatening). This case, from the same reporter is linked to 20210417723.; Sender's Comments: v0 This report involves a female patient of unspecified age who experienced lightheadedness, then fainted, had a seizure, stopped breathing and developed cyanosis about 5 minutes after receiving Janssen COVID-19 Vaccine Ad26.COV2.S for prophylactic vaccination. Given the close temporal relationship the events are considered possibly related to the vaccination.
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Neck pain, Oxygen saturation, Pharyngeal swelling, Tachycardia, Throat irritation
Clinical narrative: FAINTED; SEIZURE; STOPPED BREATHING; LIGHT HEADED; CYANOSIS; This spontaneous report received from a health care professional (public health nurse) concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 043A21A, and expiry: 31-DEC-2069) dose was not reported, 1 total, administered on left arm on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, about 5 minutes after vaccination, the patient experienced lightheadedness, then fainted, had a seizure, stopped breathing (for 10 seconds), and developed cyanosis (turned blue). The nurse did cardiopulmonary resuscitation (CPR) and the Emergency Medical Services (EMS) was called. By the time the EMS arrived, the patient felt better. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stopped breathing on 07-APR-2021, and was recovering from light headed, fainted, seizure, and cyanosis. This report was serious (Other Medically Important Condition, and Life Threatening). This case, from the same reporter is linked to 20210417723.; Sender's Comments: v0 This report involves a female patient of unspecified age who experienced lightheadedness, then fainted, had a seizure, stopped breathing and developed cyanosis about 5 minutes after receiving Janssen COVID-19 Vaccine Ad26.COV2.S for prophylactic vaccination. Given the close temporal relationship the events are considered possibly related to the vaccination.
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Apnoea, Cold sweat, Dizziness, Rash, Seizure
Clinical narrative: FAINTED; SEIZURE; STOPPED BREATHING; LIGHT HEADED; CYANOSIS; This spontaneous report received from a health care professional (public health nurse) concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 043A21A, and expiry: 31-DEC-2069) dose was not reported, 1 total, administered on left arm on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, about 5 minutes after vaccination, the patient experienced lightheadedness, then fainted, had a seizure, stopped breathing (for 10 seconds), and developed cyanosis (turned blue). The nurse did cardiopulmonary resuscitation (CPR) and the Emergency Medical Services (EMS) was called. By the time the EMS arrived, the patient felt better. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stopped breathing on 07-APR-2021, and was recovering from light headed, fainted, seizure, and cyanosis. This report was serious (Other Medically Important Condition, and Life Threatening). This case, from the same reporter is linked to 20210417723.; Sender's Comments: v0 This report involves a female patient of unspecified age who experienced lightheadedness, then fainted, had a seizure, stopped breathing and developed cyanosis about 5 minutes after receiving Janssen COVID-19 Vaccine Ad26.COV2.S for prophylactic vaccination. Given the close temporal relationship the events are considered possibly related to the vaccination.
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Speech disorder
Clinical narrative: FAINTED; SEIZURE; STOPPED BREATHING; LIGHT HEADED; CYANOSIS; This spontaneous report received from a health care professional (public health nurse) concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 043A21A, and expiry: 31-DEC-2069) dose was not reported, 1 total, administered on left arm on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, about 5 minutes after vaccination, the patient experienced lightheadedness, then fainted, had a seizure, stopped breathing (for 10 seconds), and developed cyanosis (turned blue). The nurse did cardiopulmonary resuscitation (CPR) and the Emergency Medical Services (EMS) was called. By the time the EMS arrived, the patient felt better. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stopped breathing on 07-APR-2021, and was recovering from light headed, fainted, seizure, and cyanosis. This report was serious (Other Medically Important Condition, and Life Threatening). This case, from the same reporter is linked to 20210417723.; Sender's Comments: v0 This report involves a female patient of unspecified age who experienced lightheadedness, then fainted, had a seizure, stopped breathing and developed cyanosis about 5 minutes after receiving Janssen COVID-19 Vaccine Ad26.COV2.S for prophylactic vaccination. Given the close temporal relationship the events are considered possibly related to the vaccination.
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cyanosis, Dizziness, Respiratory arrest, Seizure, Syncope
Clinical narrative: FAINTED; SEIZURE; STOPPED BREATHING; LIGHT HEADED; CYANOSIS; This spontaneous report received from a health care professional (public health nurse) concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 043A21A, and expiry: 31-DEC-2069) dose was not reported, 1 total, administered on left arm on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, about 5 minutes after vaccination, the patient experienced lightheadedness, then fainted, had a seizure, stopped breathing (for 10 seconds), and developed cyanosis (turned blue). The nurse did cardiopulmonary resuscitation (CPR) and the Emergency Medical Services (EMS) was called. By the time the EMS arrived, the patient felt better. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stopped breathing on 07-APR-2021, and was recovering from light headed, fainted, seizure, and cyanosis. This report was serious (Other Medically Important Condition, and Life Threatening). This case, from the same reporter is linked to 20210417723.; Sender's Comments: v0 This report involves a female patient of unspecified age who experienced lightheadedness, then fainted, had a seizure, stopped breathing and developed cyanosis about 5 minutes after receiving Janssen COVID-19 Vaccine Ad26.COV2.S for prophylactic vaccination. Given the close temporal relationship the events are considered possibly related to the vaccination.